| Antimony toxicity S Sundar, J Chakravarty International journal of environmental research and public health 7 (12 …, 2010 | 791 | 2010 |
| Single-dose liposomal amphotericin B for visceral leishmaniasis in India S Sundar, J Chakravarty, D Agarwal, M Rai, HW Murray New England Journal of Medicine 362 (6), 504-512, 2010 | 499 | 2010 |
| Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ... The Lancet 377 (9764), 477-486, 2011 | 389 | 2011 |
| Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ... Clinical infectious diseases 55 (4), 543-550, 2012 | 352 | 2012 |
| An update on pharmacotherapy for leishmaniasis S Sundar, J Chakravarty Expert opinion on pharmacotherapy 16 (2), 237-252, 2015 | 338 | 2015 |
| Leishmaniasis: an update of current pharmacotherapy S Sundar, J Chakravarty Expert opinion on pharmacotherapy 14 (1), 53-63, 2013 | 336 | 2013 |
| Drug resistance in leishmaniasis J Chakravarty, S Sundar Journal of global infectious diseases 2 (2), 167-176, 2010 | 327 | 2010 |
| New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine S Sundar, M Rai, J Chakravarty, D Agarwal, N Agrawal, M Vaillant, ... Clinical Infectious Diseases 47 (8), 1000-1006, 2008 | 248 | 2008 |
| Liposomal amphotericin B and leishmaniasis: dose and response S Sundar, J Chakravarty Journal of global infectious diseases 2 (2), 159-166, 2010 | 233 | 2010 |
| Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective O Prakash Singh, B Singh, J Chakravarty, S Sundar Infectious diseases of poverty 5 (02), 1-15, 2016 | 206 | 2016 |
| A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+ MPL-SE vaccine for use in the prevention of visceral leishmaniasis J Chakravarty, S Kumar, S Trivedi, VK Rai, A Singh, JA Ashman, ... Vaccine 29 (19), 3531-3537, 2011 | 191 | 2011 |
| Current and emerging medications for the treatment of leishmaniasis J Chakravarty, S Sundar Expert opinion on pharmacotherapy 20 (10), 1251-1265, 2019 | 174 | 2019 |
| Paromomycin in the treatment of leishmaniasis S Sundar, J Chakravarty Expert opinion on investigational drugs 17 (5), 787-794, 2008 | 155 | 2008 |
| Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody S Sundar, R Maurya, RK Singh, K Bharti, J Chakravarty, A Parekh, M Rai, ... Journal of Clinical Microbiology 44 (1), 251-253, 2006 | 130 | 2006 |
| High incidence of zidovudine induced anaemia in HIV infected patients in eastern India D Agarwal, J Chakravarty, L Chaube, M Rai, NR Agrawal, S Sundar Indian Journal of Medical Research 132 (4), 386-389, 2010 | 119 | 2010 |
| Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions S Sundar, J Chakravarty, VK Rai, N Agrawal, SP Singh, V Chauhan, ... Clinical Infectious Diseases 45 (5), 556-561, 2007 | 118 | 2007 |
| Study on clinico-epidemiological profile of HIV patients in eastern India J Chakravarty, H Mehta, A Parekh, SVS Attili, NR Agrawal, SP Singh, ... Japi 54, 854-7, 2006 | 105 | 2006 |
| Diagnosis of Indian visceral leishmaniasis by nucleic acid detection using PCR P Srivastava, S Mehrotra, P Tiwary, J Chakravarty, S Sundar PloS one 6 (4), e19304, 2011 | 102 | 2011 |
| Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study G Kumar, A Mukherjee, RK Sharma, GR Menon, D Sahu, N Wig, S Panda, ... Indian Journal of Medical Research 153 (5-6), 619-628, 2021 | 92 | 2021 |
| Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study OP Singh, P Tiwary, AK Kushwaha, SK Singh, DK Singh, P Lawyer, ... The Lancet Microbe 2 (1), e23-e31, 2021 | 82 | 2021 |
